Medicare Unlocks Affordable GLP-1s: $50 Monthly for Weight Loss, But Not For Everyone
A game-changing shift just hit millions of older Americans: Starting July 1, 2026, Medicare is now covering certain popular GLP-1 weight loss drugs for a fixed $50 monthly co-pay through a temporary 'Medicare GLP-1 Bridge' program. This move shatters a longstanding prohibition on Medicare paying for medications solely for weight loss, making expensive treatments like Wegovy, Zepbound, and Foundayo suddenly affordable for eligible beneficiaries across the country.












